Breast Cancer

News

Hypothesis for mechanism of action of IL-34 in TNBC
21 Aug 2020
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.

Events

Sorry, no events coming up for this topic.

Researchers

Sorry, no researchers coming up for this topic.